CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
Condition: Shock, Cardiogenic Interventions: Drug: Dobutamine; Drug: Milrinone; Drug: Normal Saline Sponsor: Ottawa Heart Institute Research Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials